We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Detention services order 05/2018 about Home Office policy on detainees having mobile phones and cameras in removal centres.
This Freedom of Information request outlines information on future expenditure on IT equipment.
The MHRA has become increasingly aware of infrared thermometers being sold in the UK that do not comply with the regulations.
New analysis showing that lateral flow tests (LFDs) have a specificity of at least 99.9% when used to test in the community, and could be as high as 99.97%.
Recommendations on leadless cardiac pacemaker therapy from MHRA Expert Advisory Group
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 April 2024) approved the medicine fosdenopterin (Nulibry) to treat the genetic disease Molybdenum Cofactor Deficiency (MoCD) Type A
List of Field Safety Notices from 18 to 22 September 2023.
£16.6 million investment announced today to give semiconductor researchers and businesses access to new equipment helping them test and make chips for use in high-energy machines like electric cars and manufacturing equipment.
First published during the 2022 to 2024 Sunak Conservative government
List of Field Safety Notices from 18 to 22 December 2023
Applications are now open for Integrated care systems to apply for a share of £30 million to roll out innovative technology
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Galderma (U.K.) Limited has informed the MHRA that a pallet of Loceryl 5% w/v Medicated Nail Lacquer from a batch licensed only for distribution in Ireland has been inadvertently placed into the UK supply chain due to a warehousing error...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).